Search Results - "Mele Olive, J"

Change in treatment decisions according to Oncotype Dx Recurrence Score in node positive and negative, estrogen-receptor positive (ER+), HER2 negative breast cancer in a single institution by Gasol Cudos, A, Morales Murillo, S, Panades Siurana, M.J, Vilardell Villellas, F, Canosa Morales, C, Mele Olive, J, Iglesias Martinez, E, Salud Salvia, A

Get full text

A Simple Modified Scissor for Combined Dissection, Cut and Ligation by Pérez-Ruiz, L., Herrerias-González, F., Mele-Olive, J., Gas-Ruiz, C.

Get full text

230P Pathologic response to neoadjuvant therapy in HER2 positive/oestrogen receptor positive breast cancer patients by Gasol Cudos, A., Morales, S., Rodriguez Galindo, A., Velasco Sanchez, A., Serrate Lopez, A., Mele Olive, J., Canosa Morales, C.

Get full text

Vitamin D as a prognostic factor in triple negative early breast cancer by Morales, S., Gasol Cudos, A., Novell Alvarez, A., Vilardell Villellas, F., Panades Siurana, M.J., Canosa Morales, C., Mele Olive, J., Iglesias Martinez, E.

Get full text

P211 - Change in treatment decisions according to Oncotype Dx Recurrence Score in node positive and negative, estrogen-receptor positive (ER+), HER2 negative breast cancer in a single institution by Gasol Cudos, A., Morales Murillo, S., Panades Siurana, M.J., Vilardell Villellas, F., Canosa Morales, C., Mele Olive, J., Iglesias Martinez, E., Salud Salvia, A.

Get full text

P011 Utility of oncotype in premenopausal women with hormonal receptor (hr) positive her2 negative early breast cancer by Cudós, A. Gasol, Murillo, S. Morales, Der-Abrain, N. Tuset, Guzmán, D.R. Sánchez, Villellas, F. Vilardell, orillo, E. Morera M, Morales, C. Canosa, Olivé, J. Melé, Cid, L. Arbonés

Get full text

Assesment of endocrine sensitivity in primary breast cancer through RS Score and changes in the proliferation index KI67 by Gasol Cudos, A., Morales Murillo, S., Pallisé Subirats, O., Rodriguez Galindo, A., Veas Rodriguez, J., Sanchez Guzman, D.R., Vilardell Villellas, F., Canosa Morales, C., Melé Olivé, J., Iglesias Martinez, E.

Get full text

Abstract P2-08-30: Vitamin D as a prognostic factor in triple negative early breast cancer by Morales Murillo, S, Gasol Cudos, A, Veas Rodriguez, J, Santacana, M, Canosa Morales, C, Mele Olivé, J

“…Abstract Background: Triple negative breast cancer is a special phenotype where the pathological complete response (pCR) remains the most important factor but…”
Get full text

Abstract P3-08-24: Mutational characterization of HER2-positive breast cancer by Velasco Sánchez, A, Gasol Cudos, A, Morales, S, Veas Rodriguez, J, Serrate López, A, Mele Olivé, J, Canosa Morales, C

“…Abstract Background: Studies of mutational analysis have been widely reported in various global series of breast cancer. However, in the era of different…”
Get full text

Quiste pericárdico by Gervilla Caño, J, Soler González, J, Melé Olivé, J, Domingo Salvany, P, Mayolas Saura, E, Oriol Zerbe, C

“…ResumenLos quistes pericárdicos son raros, habitualmente asintomáticos y su descubrimiento suele ser casual. Presentamos el caso de un paciente con un quiste…”
Get full text

228P Pathologic response to neoadjuvant antiher2 therapy in HER2 equivocal overexpression with FISH amplification by Morales, S., Gasol Cudos, A., Rodriguez Galindo, A., Serrate Lopez, A., Velasco Sanchez, A., Melé Olivé, J., Canosa Morales, C.

Get full text

103P Loss of HER2 after neoadjuvant treatment of HER2+ early breast cancer by Morales, S., Gasol Cudos, A., Rodriguez Galindo, A., Velasco, A., Canosa Morales, C., Sánchez Guzmán, D.-R., Melé Olivé, J.

Get full text

180P Relapse pattern after neoadjuvant treatment in early breast cancer by Gasol Cudos, A., Morales Murillo, S., Pallisé Subirats, O., Vilardell Villellas, F., Sánchez Guzman, D.R., Canosa Morales, C., Melé Olivé, J., Velasco Sánchez, A., Cordoba Ortega, J.F.

Get full text

Pathologic response and survival efficacy in patients with initial nodal involvement after neoadjuvant chemotherapy in early breast cancer by Murillo, S Morales, Cudos, A Gasol, Rodriguez, J Veas, Villellas, F Vilardell, Guzmán, D -R Sánchez, Morales, C Canosa, Olivé, J Melé, el Koulali, I., Martínez, E Iglesias

Get full text

266PPathologic response and survival efficacy in patients with initial nodal involvement after neoadjuvant chemotherapy in early breast cancer by Murillo, S Morales, Cudos, A Gasol, Rodriguez, J Veas, Villellas, F Vilardell, Guzmán, D -R Sánchez, Morales, C Canosa, Olivé, J Melé, el Koulali, I, Martínez, E Iglesias

“…Abstract Background Nodal involvement is a common prognostic factor in early breast cancer (EBC) but their response and assessment after neoadjuvant…”
Get full text

266P - Pathologic response and survival efficacy in patients with initial nodal involvement after neoadjuvant chemotherapy in early breast cancer by Murillo, S Morales, Cudos, A Gasol, Rodriguez, J Veas, Villellas, F Vilardell, Guzmán, D -R Sánchez, Morales, C Canosa, Olivé, J Melé, el Koulali, I., Martínez, E Iglesias

“…Nodal involvement is a common prognostic factor in early breast cancer (EBC) but their response and assessment after neoadjuvant chemotherapy (NAC) is…”
Get full text

Abstract P3-10-17: mRNA expression of HER2 by PCR as a strong predictor of pathologic response to neoadjuvant antiHER2 therapy by Gasol Cudós, A, Morales Murillo, S, Veas Rodriguez, J, Velasco Sánchez, A, Serrate López, A, Melé Olivé, J, Canosa Morales, C

“…Abstract Background: Pathologic response to neoadjuvant therapy is the most important prognostic factor so new agents should aim to improve it. HER2 expression…”
Get full text

278P - Correlation between radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer and pathologic complete response and their impact in recurrence-free survival by Cudos, A Gasol, Murillo, S Morales, Rodriguez, J Veas, Ortega, J F Córdoba, García, M I Gil, Morales, C Canosa, Olivé, J Melé, el Koulali, I., Martínez, E Iglesias

“…Patients with early breast cancer (EBC) achieving pathologic complete response (pCR) after neoadjuvant chemotherapy (NACT) have a favorable prognosis. Breast…”
Get full text

278PCorrelation between radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer and pathologic complete response and their impact in recurrence-free survival by Cudos, A Gasol, Murillo, S Morales, Rodriguez, J Veas, Ortega, J F Córdoba, García, M I Gil, Morales, C Canosa, Olivé, J Melé, el Koulali, I, Martínez, E Iglesias

“…Abstract Background Patients with early breast cancer (EBC) achieving pathologic complete response (pCR) after neoadjuvant chemotherapy (NACT) have a favorable…”
Get full text

Correlation between radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer and pathologic complete response and their impact in recurrence-free survival by Cudos, A Gasol, Murillo, S Morales, Rodriguez, J Veas, Ortega, J F Córdoba, García, M I Gil, Morales, C Canosa, Olivé, J Melé, el Koulali, I., Martínez, E Iglesias

Get full text